How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

Related Videos

January 10, 2019

Immunotherapy vs Targeted Therapy

Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.

October 1, 2014

Navigating Through the Healthcare System

Atheer Kaddis presents his own personal advice on what pharmacists should do to navigate through the healthcare system.Supported through funding from Incyte